Seminar "The Economic Returns to Delayed Aging: Promises and Pitfalls” by Dana Goldman

Wednesday, December 6, 2017

**Please note: the date and time for this seminar have changed. The information below is correct.  We hope you can join us on Wednesday, December 6, at 9:30 a.m.**

Please join us on Wednesday, December 6, at 9:30 a.m. for this seminar.  Dana Goldman, PhD, Founding Director, Distinguished Professor, and Leonard D. Schaeffer Director’s Chair, Schaeffer Center for Health Policy & Economics, University of Southern California, will present "The Economic Returns to Delayed Aging: Promise and Pitfalls.”

To attend, please RSVP to: The event takes place at the HPM Conference Room, Allan Rosenfield Building Room 440, 722 W. 168th Street.

Abstract: Most medical research remains focused on combating individual diseases, despite robust evidence that delayed aging remains a realistic goal. Using the Future Elderly Model—a microsimulation of future health and spending of older Americans—we compared optimistic “disease specific” scenarios with a “delayed aging” scenario to see their effects on longevity, disability, and Federal spending.  We find that delayed aging is a particularly good investment, as it could increase life expectancy by an additional 2.2 years, most of which would be spent in good health.  The value to society is $7 trillion over fifty years.  Disease-specific investments have more modest returns, mainly due to competing risks.  The fiscal challenges of delayed aging are manageable through modest policy changes. Overall, more research to delay aging appears to be a highly efficient way to forestall disease, extend healthy life, and improve public health—albeit with the potential to exacerbate existing health disparities.


171206 Goldman Plasma FINAL sm.jpg

30 a.m.